-
Decomposing the "Weight Loss Drug" Capital Feast: Novo Nordisk and Lilly Struggle for Nearly 20 Years, True and False Concepts Fly Together
If you want to select the concept with the highest attention in the capital market in 2023, the "slimming elixir" is undoubtedly the best choice. Musk's shout, the years of entanglement between the t ... -
US stock year-end inventory: from giant dance to crow feast, "best analyst" sighs and admits mistakes
AI, weight loss pills, and Bitcoin are taking turns to enter the market, facing a market that has turned "thunderous waves" into "rising waves". Even the "best strategic analyst on Wall Street" can o ... -
The AI feast continues: Wall Street's "smart money" flooded into technology stocks last week, marking the largest scale in over a year
Although last week's Meta financial report and phone conference performance once raised doubts about the prospects of artificial intelligence investment in the market, the strong financial reports of ...